- Sections
- C - Chimie; métallurgie
- C07H - Sucres; leurs dérivés; nucléosides; nucléotides; acides nucléiques
- C07H 15/20 - Carbocycles
Détention brevets de la classe C07H 15/20
Brevets de cette classe: 127
Historique des publications depuis 10 ans
9
|
7
|
8
|
10
|
3
|
8
|
11
|
2
|
5
|
0
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
Cipla USA, Inc. | 28 |
5 |
Glycosynth Limited | 5 |
4 |
Centre National de La Recherche Scientifique | 9632 |
3 |
Vertex Pharmaceuticals Incorporated | 1581 |
3 |
The Coca-Cola Company | 2528 |
3 |
Infectious Disease Research Institute | 46 |
3 |
The University of British Columbia | 1432 |
3 |
Merck Sharp & Dohme B.V. | 485 |
2 |
CHDI Foundation, Inc. | 104 |
2 |
The Governors of the University of Alberta | 869 |
2 |
Her Majesty The Queen in Right of Canada, AS represented by The Minister of Agriculture and Agri-food | 100 |
2 |
Ionis Pharmaceuticals, Inc. | 776 |
2 |
PureCircle Sdn Bhd | 223 |
2 |
Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd. | 3 |
2 |
TriAct Therapeutics, Inc. | 14 |
2 |
Unigen, Inc. | 25 |
2 |
Unigen, Inc. | 118 |
2 |
University of Georgia Research Foundation, Inc. | 972 |
2 |
University of Washington through its Center for Commercialization | 498 |
2 |
Washington University | 1473 |
2 |
Autres propriétaires | 77 |